Evidence map›Paper›PMID 37676382›Full record

ReviewJapanese journal of radiology2024

An overview on multimodal imaging for the diagnostic workup of pleural mesothelioma.

Michela Gabelloni, Lorenzo Faggioni, Maria Chiara Brunese, Carmine Picone, Roberta Fusco, Giovanni Donato Aquaro, Dania Cioni, Emanuele Neri, Nicoletta Gandolfo, Andrea Giovagnoni and 1 more

Abstract readReview
In one paragraph

Review in Japanese journal of radiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Malignant Pleural Mesothelioma CT Imaging: How to Measure It Correctly?Cancer control : journal of the Moffitt Cancer Center
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Michela Gabelloni *Nuclear Medicine Unit, Department of Translational Research, University of Pisa, Via Roma 67, 56126, Pisa, Italy.
Lorenzo Faggioni *Academic Radiology, Department of Translational Research, University of Pisa, 56126, Pisa, Italy. lorenzo.faggioni@unipi.it.ORCID http://orcid.org/0000-0001-5262-4489
Maria Chiara BruneseDiagnostic Imaging Section, Department of Medical and Surgical Sciences and Neurosciences, University of Molise, 86100, Campobasso, Italy.
Carmine PiconeDivision of Radiology, Istituto Nazionale Tumori IRCCS Fondazione Pascale-IRCCS di Napoli, 80131, Naples, Italy.
Roberta FuscoMedical Oncology Division, Igea SpA, 80013, Naples, Italy.
Giovanni Donato AquaroAcademic Radiology, Department of Translational Research, University of Pisa, 56126, Pisa, Italy.
Dania CioniAcademic Radiology, Department of Translational Research, University of Pisa, 56126, Pisa, Italy.
Emanuele NeriAcademic Radiology, Department of Translational Research, University of Pisa, 56126, Pisa, Italy.
Nicoletta GandolfoDiagnostic Imaging Department, Villa Scassi Hospital-ASL 3, 16149, Genoa, Italy.
Andrea GiovagnoniDepartment of Radiology, University Hospital "Azienda Ospedaliera Universitaria Delle Marche", 60126, Ancona, Italy.
Vincenza GranataDivision of Radiology, Istituto Nazionale Tumori IRCCS Fondazione Pascale-IRCCS di Napoli, 80131, Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pleural mesothelioma (PM) is an aggressive disease that has a strong causal relationship with asbestos exposure and represents a major challenge from both a diagnostic and therapeutic viewpoint. Despite recent improvements in patient care, PM typically carries a poor outcome, especially in advanced stages. Therefore, a timely and effective diagnosis taking advantage of currently available imaging techniques is essential to perform an accurate staging and dictate the most appropriate treatment strategy. Our aim is to provide a brief, but exhaustive and up-to-date overview of the role of multimodal medical imaging in the management of PM.

Indexed as

MesotheliomaPleural NeoplasmsHumansMultimodal ImagingNeoplasm StagingRisk FactorsMultimodal imagingPleural mesotheliomaRadiomicsStaging

Identifiers

PMID37676382
PMCPMC10764410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.